Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease

HIV Medicine

Volumn 10, Issue 8, 2009, Pages 488-495

  Grau, I ^a   Ardanuy, C ^a   Linares J ^a   Podzamczer, D ^a   Schulze, M H ^a   Pallares, R ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

AIDS; Antibiotic resistance; HIV infected patients; Mortality; Pneumococcal disease; Serotypes; Streptococcus pneumoniae

Indexed keywords

ANTIRETROVIRUS AGENT; CEFOTAXIME; CEFTRIAXONE; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; PNEUMOCOCCUS CONJUGATE VACCINE 7; PNEUMOCOCCUS VACCINE; TETRACYCLINE; UNCLASSIFIED DRUG;

ADULT; ALCOHOL ABUSE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INVASIVE PNEUMOCOCCAL DISEASE; LEUKOPENIA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SEROTYPE; SHOCK; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TREND STUDY;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; DRUG RESISTANCE, BACTERIAL; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MORTALITY; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SEROTYPING; SPAIN; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 68449089439     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2009.00717.x     Document Type: Article

References (32)

1. Mocroft A, Ledergerber B, Katlama C et al. for the EuroSIDA Study Group. Decline in the AIDS and death rates in the EuroSIDA Study: An observational study. Lancet 2003; 362: 22-29.
2. Nuorti JP, Butler JC, Gelling L, Kool JL, Reingold AL, Vugia DJ. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med 2000; 132: 182-190.
3. Saindou M, Chidiac C, Miailhes P et al. Pneumococcal pneumonia in HIV-infected patients by antiretroviral therapy periods. HIV Med 2008; 9: 203-207.
4. Heffernan RT, Barrett NL, Gallagher KM et al. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J Infect Dis 2005; 191: 2038-2045.
5. Curran A, Falco V, Crespo M et al. Bacterial pneumonia in HIV-infected patients: Use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome. HIV Med 2008; 9: 609-615.
6. Flannery B, Heffernan RT, Harrison LH et al. Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med 2006; 144: 1-9.
7. Barry PM, Zetola N, Keruly JC, Moore RD, Gebo KA, Lucas GM. Invasive pneumococcal disease in a cohort of HIV-infected adults: Incidence and risk factors, 1990-2003. AIDS 2006; 20: 437-444.
8. Jordano Q, Falco V, Almirante B et al. Invasive pneumococcal disease in patients infected with HIV: Still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis 2004; 38: 1623-1628.
9. Sogaard OS, Lohse N, Gerstoft J et al. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: A Danish population-based, nationwide cohort study. Clin Infect Dis 2008; 47: 1345-1353.
10. Grau I, Pallares R, Tubau F et al. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med 2005; 165: 1533-1540.
11. Clinical and Laboratory Standard Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard: 7th edition. CLSI Document M7-A6. Wayne, PA: CLSI, 2006.
12. Clinical Laboratory Standard Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; 18th Informational Supplement. CLSI Document M100-S18. Wayne, PA: CLSI, 2008.
13. McGee L, McDougal L, Zhou J et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol 2001; 39: 2565-2571.
14. Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: Identification of clones associated with serious invasive disease. Microbiology 1998; 144: 3049-3060.
15. Calbo E, Diaz A, Cañadell E et al. for the Spanish Pneumococcal Infection Study Network. Invasive pneumococcal disease among children in a health district of Barcelona: Early impact of pneumococcal conjugate vaccine. Clin Microbiol Infect 2 006; 12: 867-872.
16. Muñoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia JJ, Pallares R. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 2008; 46: 174-182.
17. Janoff EN, O'Brien J, Thompson P et al. Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J Infect Dis 1993; 167: 49-56.
18. Pallares R, Liñares J, Vadillo M et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333: 474-480.
19. García-Leoni ME, Moreno S, Rodeñó P, Cercenado E, Vicente T, Bouza E. Pneumococcal pneumonia in adult hospitalized patients infected with the human immunodeficiency virus. Arch Intern Med 1992; 152: 1808-1812.
20. Feikin DR, Feldman C, Schuchat A, Janoff EN. Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis 2004; 4: 445-455.
21. Feldman C, Klugman KP, Yu VL et al. and the International Pneumococcal Study Group. Bacteraemic pneumococcal pneumonia: Impact of HIV on clinical presentation and outcome. J Infect 2007; 55: 125-135.
22. Palella FJ Jr, Baker RK, Moorman AC et al. HIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV Outpatient Study. J Acquir Immune Defic Syndr 2006; 43: 27-34.
23. The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349: 1993-2003.
24. Walli R, Herfort O, Michl GM et al. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS 1998; 12: F167-F173.
25. Crum-Cianflone N, Hullsiek KH, Marconi V et al. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: A 20-year cohort study. AIDS 2009; 23: 41-50.
26. Castellares C, Barreiro P, Martín-Carbonero L et al. Liver cirrhosis in HIV-infected patients: Prevalence, aetiology and clinical outcome. J Viral Hepat 2008; 15: 165-172.
27. Anderson KB, Guest JL, Rimland D. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: Data from the HIV Atlanta VA Cohort Study. Clin Infect Dis 2004; 39: 1507-1513.
28. Alanee SR, McGee L, Jackson D et al. for the International Pneumococcal Study Group. Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: An international study. Clin Infect Dis 2007; 45: 46-51.
29. Lexau CA, Lynfield R, Danila R et al. for the Active Bacterial Core Surveillance Team. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005; 294: 2043-2051.
30. Jacobs MR, Good CE, Bajaksouzian S, Windau AR. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis 2008; 47: 1388-1395.
31. Ardanuy C, Tubau F, Pallares R et al. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis 2009; 48: 57-64.
32. Sjöström K, Blomberg C, Fernebro J et al. Clonal success of piliated penicillin nonsusceptible pneumococci. Proc Natl Acad Sci USA 2007; 104: 12907-12912.